Table 2.

Correlation (p-value) of significant immune-system-related for IPSS/QOL in the patients with prostate inflammation

	incomplete emptying	diurnal frequency	intermittency	urgency	weak flow	straining to void
scores	1.93 ± 1.53	2.60 ± 1.41	2.17 ± 1.55	2.20 ± 1.60	2.88 ± 1.34	1.68 ± 1.53
IL-6	n.s.	n.s.	n.s.	n.s.	n.s.	n.s.
CD-3	n.s.	0.0387 ** (r = -0.3310)	n.s.	n.s.	n.s.	n.s.
CD-163	n.s.	n.s.	n.s.	n.s.	n.s.	n.s.
		frequency at night	voided symptoms***	storage symptoms****	Total	QOL
scores		2.28 ± 1.11	6.70 ± 3.82	9.10 ± 4.50	15.83 ± 7.90	3.73 ± 1.52
IL-6		n.s.	n.s.	n.s.	n.s.	n.s.
CD-3		n.s.	n.s.	n.s.	n.s.	n.s.
CD-163		n.s.	n.s.	n.s.	n.s.	n.s.

^*n.s.: not significant.

^**bold: statistically significant.

^***voided symptoms consist of intermittency, weak flow, and straining to void.

^****storage symptoms consist of incomplete emptying, diurnal frequency, urgency, and nocturia.